Sourcebio International PLC
LSE:SBI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Kinetic Development Group Ltd
HKEX:1277
|
CN |
|
K
|
KPM Tech Co Ltd
KOSDAQ:042040
|
KR |
|
Lasa Supergenerics Ltd
NSE:LASA
|
IN |
|
S
|
Swing Media Technology Group Ltd
SGX:BEV
|
HK |
|
N
|
Net A Go Technology Co Ltd
HKEX:1483
|
HK |
|
Perella Weinberg Partners
NASDAQ:PWP
|
US |
|
L
|
Lena Lighting SA
WSE:LEN
|
PL |
|
Stockwik Forvaltning AB
STO:STWK
|
SE |
|
Q
|
Qumu Corp
F:RMG
|
US |
|
N
|
Nordhealth AS
OSE:NORDH
|
NO |
|
Tarsons Products Ltd
NSE:TARSONS
|
IN |
|
Lamprell Plc
LSE:LAM
|
AE |
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| UK |
|
Sourcebio International PLC
LSE:SBI
|
85.3m GBP |
Loading...
|
|
| US |
|
CVS Health Corp
NYSE:CVS
|
99.4B USD |
Loading...
|
|
| US |
C
|
Cigna Group
XMUN:CGN
|
69.6B EUR |
Loading...
|
|
| US |
|
Cigna Corp
NYSE:CI
|
72.3B USD |
Loading...
|
|
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
24.3B EUR |
Loading...
|
|
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23B EUR |
Loading...
|
|
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
22.1B USD |
Loading...
|
|
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.6B USD |
Loading...
|
|
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.9B EUR |
Loading...
|
|
| US |
|
Guardant Health Inc
NASDAQ:GH
|
12.2B USD |
Loading...
|
|
| US |
|
DaVita Inc
NYSE:DVA
|
10.3B USD |
Loading...
|
Market Distribution
| Min | -195 650% |
| 30th Percentile | 0% |
| Median | 0.1% |
| 70th Percentile | 0.2% |
| Max | 4 630.7% |
Other Profitability Ratios
Sourcebio International PLC
Glance View
SourceBio International Plc engages in the provision of laboratory services in healthcare, clinical, life science research, and biopharma industries. The company is headquartered in Nottingham, Nottinghamshire. The company went IPO on 2020-10-29. The firm operates through four business segments: Infectious Disease Testing, Healthcare Diagnostics, Genomics and Stability Storage. Its Infectious Disease Testing segment offers COVID-19 antigen reverse transcription-polymerase chain reaction (RT-PCR) testing services to the national health service (NHS), private healthcare providers and private industry. Its Healthcare Diagnostics segment offers histopathology and clinical diagnostic services for the NHS and private healthcare across the United Kingdom and Ireland. Its Genomics segment offers deoxyribonucleic acid (DNA) sequencing services for pharmaceutical and biotechnology companies, academia, contract research organizations (CROs) and other research groups in the United Kingdom, Europe and North America. Its Stability Storage segment offers shelf-life testing services and equipment for pharmaceutical companies and others.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
Over the last 2 years, Sourcebio International PLC’s Operating Margin has decreased from 24% to 15.8%. During this period, it reached a low of 15.8% on Jul 30, 2022 and a high of 27.7% on Jun 30, 2021.
